Hospital group purchasing organization Premier awards new deals to device giants including Medtronic, St. Jude, and Boston Scientific for drug eluting stents, traditional stents and other cardiac intervention products.
Premier Healthcare Alliance awarded several new contracts for drug-eluting stents, traditional stents and other intervention products to 8 heavy hitters in the cardiology space.
Abbott (NYSE:ABT), Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) all landed supplier deals for drug-eluting and traditional stents.
